{"id":524644,"date":"2025-03-08T17:26:01","date_gmt":"2025-03-08T14:26:01","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=524644"},"modified":"2025-03-08T17:26:01","modified_gmt":"2025-03-08T14:26:01","slug":"oamenii-de-stiinta-trag-un-semnal-de-alarma-un-antibiotic-cu-risc-scazut-a-dus-la-aparitia-unei-superbacterii-aproape-netratabile","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=524644","title":{"rendered":"Oamenii de \u015ftiin\u0163\u0103 trag un semnal de alarm\u0103: Un antibiotic \u201ecu risc sc\u0103zut\u201d a dus la apari\u0163ia unei superbacterii aproape netratabile"},"content":{"rendered":"<div class=\"post-content\">\n<p>Un studiu recent arat\u0103 c\u0103 un antibiotic utilizat pentru pacien\u0163ii cu afec\u0163iuni hepatice le poate cre\u015fte riscul de a contracta o superbacterie periculoas\u0103, transmite News.ro.<\/p>\n<p>O echip\u0103 interna\u0163ional\u0103 de cercet\u0103tori a descoperit c\u0103 rifaximina, un antibiotic prescris frecvent pacien\u0163ilor cu afec\u0163iuni hepatice, contribuie la cre\u015fterea la nivel mondial a unei tulpini foarte rezistente de Enterococcus faecium rezistent la vancomicin\u0103 (VRE). Aceast\u0103 superbacterie, care provoac\u0103 frecvent infec\u0163ii grave la pacien\u0163ii spitaliza\u0163i, devine din ce \u00een ce mai dificil de tratat.<\/p>\n<p>Studiul arat\u0103 c\u0103 utilizarea rifaximinei accelereaz\u0103 rezisten\u0163a la daptomicin\u0103 \u2013 unul dintre ultimele antibiotice eficiente \u00eempotriva infec\u0163iilor cu ERV.<\/p>\n<p>Derulat\u0103 de oameni de \u015ftiin\u0163\u0103 de la Institutul Peter Doherty pentru infec\u0163ii \u015fi imunitate al Universit\u0103\u0163ii din Melbourne \u015fi de la spitalul Austin Health, cercetarea subliniaz\u0103 necesitatea urgent\u0103 de a \u00een\u0163elege mai bine consecin\u0163ele neinten\u0163ionate ale utiliz\u0103rii antibioticelor. Cercetarea subliniaz\u0103 importan\u0163a vital\u0103 a prescrierii responsabile de antibiotice pentru a atenua r\u0103sp\u00e2ndirea rezisten\u0163ei antimicrobiene.<\/p>\n<p>Constat\u0103rile lor consolideaz\u0103 recenta\u00a0<a href=\"https:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/108\/2024\/09\/FINAL-Text-AMR-to-PGA.pdf\" target=\"_self\">declara\u0163ie politic\u0103<\/a>\u00a0a Reuniunii la nivel \u00eenalt a Adun\u0103rii Generale a ONU privind rezisten\u0163a antimicrobian\u0103 (26 septembrie 2024), \u00een cadrul c\u0103reia liderii mondiali s-au angajat s\u0103\u00a0<a href=\"https:\/\/www.unep.org\/news-and-stories\/press-release\/world-leaders-commit-decisive-action-antimicrobial-resistance\" target=\"_self\">ia m\u0103suri decisive privind rezisten\u0163a antimicrobian\u0103 (RAM)<\/a>, inclusiv reducerea cu 10 %, p\u00e2n\u0103 \u00een 2030, a num\u0103rului estimat de 4,95 milioane de decese umane asociate cu RAM pe an.<\/p>\n<p>Cum favorizeaz\u0103 rifaximina rezisten\u0163a la antibiotice<\/p>\n<p>Studiul de opt ani s-a bazat pe mai multe discipline, inclusiv microbiologia molecular\u0103, bioinformatica \u015fi \u015ftiin\u0163a clinic\u0103. Utiliz\u00e2nd genomica la scar\u0103 larg\u0103 \u2013 studiul compozi\u0163iei ADN-ului unui organism \u2013 oamenii de \u015ftiin\u0163\u0103 au reu\u015fit s\u0103 identifice modific\u0103ri \u00een ADN-ul tulpinii VRE rezistente la daptomicin\u0103 care erau absente \u00een tulpinile sensibile. Experimentele de laborator \u015fi studiile clinice ulterioare au ar\u0103tat c\u0103 utilizarea rifaximinei a cauzat aceste modific\u0103ri \u015fi a dus la apari\u0163ia ERV rezistente la daptomicin\u0103.<\/p>\n<p>Dr. Glen Carter de la Universitatea din Melbourne, cercet\u0103tor principal la Institutul Doherty \u015fi autor principal al studiului, a declarat c\u0103 cercetarea contest\u0103 convingerea de lung\u0103 durat\u0103 conform c\u0103reia rifaximina prezint\u0103 un \u201erisc sc\u0103zut\u201d de a provoca rezisten\u0163\u0103 la antibiotice.<\/p>\n<p>\u201eAm ar\u0103tat c\u0103 rifaximina face VRE rezistent\u0103 la daptomicin\u0103 \u00eentr-un mod care nu a mai fost v\u0103zut \u00eenainte\u201d, a declarat dr. Carter,\u00a0<a href=\"https:\/\/www.doherty.edu.au\/news-events\/news\/low-risk-antibiotic-has-led-to-an-almost-untreatable-superbug\" target=\"_self\">\u00eentr-un comunicat<\/a>.<\/p>\n<p>Cercet\u0103torul a subliniat c\u0103 este, de asemenea, \u00eengrijor\u0103tor faptul c\u0103 aceste VRE rezistente la daptomicin\u0103 ar putea fi transmise altor pacien\u0163i din spital; o ipotez\u0103 pe care cercet\u0103torii o investigheaz\u0103 \u00een prezent.<\/p>\n<p>Un mecanism de rezisten\u0163\u0103 \u201esupra\u00eenc\u0103rcat\u201d<\/p>\n<p>Dr. Adrianna Turner de la Universitatea din Melbourne, \u015fef de cercetare la Institutul Doherty \u015fi primul autor al studiului, a declarat c\u0103 rifaximina declan\u015feaz\u0103 schimb\u0103ri specifice \u00eentr-o enzim\u0103 numit\u0103 ARN polimeraz\u0103 \u00een cadrul bacteriei. Aceste modific\u0103ri \u201eregleaz\u0103\u201d un grup de gene necunoscut anterior (prdRAB), duc\u00e2nd la modific\u0103ri ale membranei celulare VRE \u015fi cauz\u00e2nd rezisten\u0163\u0103 \u00eencruci\u015fat\u0103 la daptomicin\u0103.<\/p>\n<p>\u201eAtunci c\u00e2nd bacteriile devin rezistente la un antibiotic, este un pic ca \u015fi cum ai dob\u00e2ndi o nou\u0103 abilitate \u00eentr-un joc video, cum ar fi super-viteza. Dar atunci c\u00e2nd sunt expuse la rifaximin\u0103, bacteriile VRE nu primesc doar un impuls, ci dob\u00e2ndesc mai multe abilit\u0103\u0163i, cum ar fi super-viteza \u015fi super-for\u0163a, ceea ce le permite s\u0103 \u00eenving\u0103 cu u\u015furin\u0163\u0103 obstacolul final, care \u00een acest caz este antibioticul daptomicin\u0103\u201d, a declarat dr. Turner.<\/p>\n<p>Cu alte cuvinte, rifaximina nu face bacteriile rezistente doar la un antibiotic; le poate face rezistente \u015fi la altele, inclusiv la antibiotice critice de ultim\u0103 linie precum daptomicina.<\/p>\n<p>Prof. univ. dr. Jason Kwong, specialist \u00een boli infec\u0163ioase la spitalul Austin Health \u015fi cercet\u0103tor principal al studiilor clinice, a subliniat dou\u0103 implica\u0163ii critice ale constat\u0103rilor.<\/p>\n<p>\u201e\u00cen primul r\u00e2nd, medicii trebuie s\u0103 fie precau\u0163i atunci c\u00e2nd trateaz\u0103 infec\u0163iile cu Enterococcus faecium rezistent la vancomicin\u0103 la pacien\u0163ii care au luat rifaximin\u0103, deoarece eficacitatea daptomicinei poate fi compromis\u0103, necesit\u00e2nd verificarea \u00een laborator \u00eenainte de utilizare\u201d, a declarat profesorul Kwong.<\/p>\n<p>\u00cen al doilea r\u00e2nd, spune el, \u201econstat\u0103rile subliniaz\u0103 importan\u0163a ca organismele de reglementare s\u0103 ia \u00een considerare efectele \u201eoff-target \u015fi cross-class\u201d atunci c\u00e2nd aprob\u0103 noi medicamente. Pentru antibiotice, asta \u00eenseamn\u0103 s\u0103 \u00een\u0163elegem dac\u0103 expunerea la un agent, cum ar fi rifaximina, ar putea induce rezisten\u0163\u0103 \u00eempotriva altor antibiotice \u2013 chiar \u015fi a celor care func\u0163ioneaz\u0103 diferit\u201d.<\/p>\n<p>\u201eRifaximina este \u00eenc\u0103 un medicament foarte eficient atunci c\u00e2nd este utilizat \u00een mod corespunz\u0103tor, iar pacien\u0163ii cu boal\u0103 hepatic\u0103 avansat\u0103 care \u00eel iau \u00een prezent ar trebui s\u0103 continue s\u0103 fac\u0103 acest lucru, dar trebuie s\u0103 \u00een\u0163elegem implica\u0163iile \u00een viitor, at\u00e2t atunci c\u00e2nd trat\u0103m pacien\u0163ii individuali, c\u00e2t \u015fi din perspectiva s\u0103n\u0103t\u0103\u0163ii publice\u201d, a precizat cercet[torul.<\/p>\n<p>Dr. Claire Gorrie de la Universitatea din Melbourne, un bioinformatician senior de la Institutul Doherty \u015fi coautor principal, spune c\u0103 cercetarea eviden\u0163iaz\u0103 modul \u00een care tehnologiile de ultim\u0103 or\u0103, combinate cu colaborarea interdisciplinar\u0103, pot descoperi exact cum \u015fi de ce bacteriile dezvolt\u0103 rezisten\u0163\u0103 la antibiotice \u2013 chiar \u015fi la cele pe care nu le-au \u00eent\u00e2lnit niciodat\u0103.<\/p>\n<p>\u201eAceste informa\u0163ii sunt cruciale pentru dezvoltarea unor strategii mai inteligente \u015fi mai durabile pentru utilizarea antibioticelor, mai ales c\u0103 aceste medicamente care salveaz\u0103 vie\u0163i devin o resurs\u0103 din ce \u00een ce mai pre\u0163ioas\u0103\u201d, a declarat dr. Gorrie.<\/p>\n<p>Profesorul Benjamin Howden, directorul Laboratorului de S\u0103n\u0103tate Public\u0103 al Unit\u0103\u0163ii de Diagnostic Microbiologic de la Institutul Doherty \u015fi medic de boli infec\u0163ioase la spitalul Austin Health, al c\u0103rui laborator a condus proiectul, a declarat c\u0103 cercetarea va contribui la asigurarea faptului c\u0103 daptomicina r\u0103m\u00e2ne un antibiotic eficient pentru tratarea infec\u0163iilor VRE severe \u00een spitalele din Australia \u015fi din \u00eentreaga lume, \u00een special la cei mai vulnerabili pacien\u0163i.<\/p>\n<p>\u201eConstat\u0103rile noastre eviden\u0163iaz\u0103 nevoia critic\u0103 de supraveghere eficient\u0103 bazat\u0103 pe genomic\u0103 pentru a detecta rezisten\u0163a antimicrobian\u0103 emergent\u0103. Ele subliniaz\u0103, de asemenea, importan\u0163a utiliz\u0103rii judicioase a antibioticelor pentru a proteja tratamentele vitale de ultim\u0103 instan\u0163\u0103, cum ar fi daptomicina\u201d, a concluzionat specialistul.<\/p>\n<p>Studiul, finan\u0163at de Consiliul Na\u0163ional pentru S\u0103n\u0103tate \u015fi Cercetare Medical\u0103 din Australia, a fost publicat \u00een revista\u00a0<a href=\"https:\/\/www.nature.com\/articles\/s41586-024-08095-4\" target=\"_self\">Nature<\/a>.<\/p>\n<\/div>\n<p> Source URL: https:\/\/www.g4media.ro\/oamenii-de-stiinta-trag-un-semnal-de-alarma-un-antibiotic-cu-risc-scazut-a-dus-la-aparitia-unei-superbacterii-aproape-netratabile.html<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un studiu recent arat\u0103 c\u0103 un antibiotic utilizat pentru pacien\u0163ii cu afec\u0163iuni hepatice le poate cre\u015fte riscul de a contracta o superbacterie periculoas\u0103, transmite News.ro. O echip\u0103 interna\u0163ional\u0103 de cercet\u0103tori a descoperit c\u0103 rifaximina, un antibiotic prescris frecvent pacien\u0163ilor cu afec\u0163iuni hepatice, contribuie la cre\u015fterea la nivel mondial a unei tulpini foarte rezistente de Enterococcus [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":524645,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24],"class_list":["post-524644","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics","tag-g4media"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/524644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=524644"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/524644\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/media\/524645"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=524644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=524644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=524644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}